Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Zoetis Aktie bricht nach enttäuschender Prognose ein (Investing.com DE) +++ ZOETIS Aktie +6,45%

EVOLENT HEALTH Aktie

 >EVOLENT HEALTH Aktienkurs 
3.21 EUR    (TradegateBSX)
Ask: 3.3 EUR / 1000 Stück
Bid: 3.12 EUR / 1060 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>EVOLENT HEALTH Performance
1 Woche: -8,1%
1 Monat: -45,5%
3 Monate: -18,6%
6 Monate: +3,8%
1 Jahr: -66,8%
laufendes Jahr: -21,4%
>EVOLENT HEALTH Aktie
Name:  EVOLENT HEALTH A DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US30050B1017 / A14UCN
Symbol/ Ticker:  9EH (Frankfurt) / EVH (NYSE)
Kürzel:  FRA:9EH, ETR:9EH, 9EH:GR, NYSE:EVH
Index:  -
Profil:  Evolent Health Inc. is a healthcare solutions company that partners with healthcare providers to enhance patient care through innovative technology and services. Primarily focused on driving value-based care, Evolent Health provides a comprehensive p..
>Volltext..
Marktkapitalisierung:  306.29 Mio. EUR
Unternehmenswert:  1014.14 Mio. EUR
Umsatz:  1638.02 Mio. EUR
EBITDA:  88.85 Mio. EUR
Nettogewinn:  -430.59 Mio. EUR
Gewinn je Aktie:  -4.13 EUR
Schulden:  854.58 Mio. EUR
Liquide Mittel:  143.96 Mio. EUR
Operativer Cashflow:  28.87 Mio. EUR
Bargeldquote:  0.44
Umsatzwachstum:  -26.27%
Gewinnwachstum:  -326.69%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel -
Suchwörter:  EVOLENT HEALTH
Letzte Datenerhebung:  06.08.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 112.48 Mio. St.
Frei handelbar: 95.73%
Rückkaufquote: 11.32%
Mitarbeiter: 4200
Umsatz/Mitarb.: 0.39 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 23.69%
Bewertung:
KGV: -
KGV lG: 25.6
KUV: 0.35
KBV: 1.32
PEG-Ratio: -
EV/EBITDA: 11.41
Rentabilität:
Bruttomarge: 14.13%
Gewinnmarge: -26.29%
Operative Marge: -0.86%
Managementeffizenz:
Gesamtkaprendite: -21.91%
Eigenkaprendite: -74.56%
>Peer Group
Gesundheit, Kliniken, Pflegeheime & Gesundheitsdienstleistungen
 
06.08.26 - 13:12
Evolent Health Non-GAAP EPS of $0.02 beats by $0.04, revenue of $652.2M beats by $52.41M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.26 - 13:03
Evolent Announces Second Quarter 2026 Results (PR Newswire)
 
WASHINGTON, Aug. 6, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced......
23.07.26 - 20:33
Evolent Health drops 16% after Citi downgrade on rising FY2027 Medicaid risk (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.07.26 - 22:33
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 (PR Newswire)
 
WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open,......
03.07.26 - 17:30
Should You Buy Evolent Health (EVH) After Golden Cross? (Zacks)
 
Is it a good or bad thing when a stock experiences a golden cross technical event?...
29.06.26 - 18:15
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength? (Zacks)
 
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road....
13.05.26 - 13:42
Evolent Health übertrifft Gewinnerwartungen in Q1 2026 – Aktie legt deutlich zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.26 - 16:45
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics (Zacks)
 
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
07.05.26 - 13:06
Evolent Announces First Quarter 2026 Results (PR Newswire)
 
WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced......
06.05.26 - 19:24
Evolent Health Q1 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.04.26 - 22:33
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 (PR Newswire)
 
WASHINGTON, April 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2026 financial results on Thursday, May 7, 2026, before market open, with......
19.03.26 - 13:48
Evolent announces appointment of Archie Mayani as chief product officer (PR Newswire)
 
Industry veteran brings track record of innovation from GHX, Change Healthcare, UnitedHealth Group and Amazon. WASHINGTON, March 19, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today......
17.03.26 - 17:24
Evolent Health: Strategische Prioritäten und Finanzziele auf Oppenheimer-Konferenz vorgestellt (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
26.02.26 - 23:03
Evolent to Participate in Upcoming Investor Conferences (PR Newswire)
 
WASHINGTON, Feb. 26, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that members of its executive management team will participate in upcoming investor conferences. A live......
25.02.26 - 16:54
Evolent Health downgraded at KeyBanc on EBITDA recovery concerns (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.02.26 - 06:00
Compared to Estimates, Evolent Health (EVH) Q4 Earnings: A Look at Key Metrics (Zacks)
 
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
25.02.26 - 05:30
Evolent Health (EVH) Q4 Earnings Top Estimates (Zacks)
 
Evolent Health (EVH) delivered earnings and revenue surprises of +28.00% and -0.11%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
24.02.26 - 22:18
Evolent Health Non-GAAP EPS of $0.08 beats by $0.03, revenue of $468.7M in-line (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.02.26 - 22:12
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results (PR Newswire)
 
WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced......
04.02.26 - 17:06
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 (PR Newswire)
 
WASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its 2025 fourth quarter and year-end financial results on Tuesday, February 24, 2026, after......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Philosophen verderben die Sprache, Poeten die Logik, und mit dem Menschenverstand kommt man durchs Leben nicht mehr. - Friedrich Johann Christoph Schiller
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!